ITGAX and COVID-19: However, the percentage of CD11c+ spike-specific IgG+ memory B cells was increased among spike-specific IgG+ B cells in patients who recovered from non-severe COVID-19 as compared to all IgG+ B cells in these patients, while this difference was not seen in individuals who recovered from severe COVID-19 (S5 Fig).